President Trump plans to fire FDA Commissioner Marty Makary, though the decision is not yet final. This move signals potential shifts in regulatory approaches and leadership at the FDA, which could impact approval processes for new technologies and treatments in healthcare. Watch for announcements on who will take over as acting director following Makary's departure.
Read the full article at Ars Technica
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)



